CRL
Charles River Laboratories International, Inc.
Stock
$290.19+3.36 (+1.17%)Close Oct 2, 2026
- Stock-based compensation, 2025
- $71M
- YoY, 2025
- +1.7%
- 5-year CAGR
- +4.8%
- 10-year CAGR
- +5.9%
Stock-based compensation
Stock-based compensation by fiscal year
| Period | Stock comp | YoY |
|---|---|---|
| 2025 | $71M | +1.7% |
| 2024 | $70M | −3.0% |
| 2023 | $72M | −2.1% |
| 2022 | $74M | +3.0% |
| 2021 | $71M | +26.9% |
| 2020 | $56M | −1.6% |
| 2019 | $57M | +21.0% |
| 2018 | $47M | +7.6% |
| 2017 | $44M | +0.8% |
| 2016 | $44M | +8.8% |
| 2015 | $40M | +29.3% |
| 2014 | $31M | +26.5% |
| 2013 | $25M | +12.3% |
| 2012 | $22M | +0.7% |
| 2011 | $22M | −15.0% |
| 2010 | $26M | +7.9% |
| 2009 | $24M | −2.3% |
| 2008 | $24M | — |